Associated Papers
Analyses of Human Genetic Data to Identify Clinically Relevant Domains of Neuroligins.
Lehr AW et al.
Genes, 2024
The synaptic hypothesis of schizophrenia version III: a master mechanism.
Howes OD et al.
Molecular Psychiatry, 2023
Using structural analysis to clarify the impact of single nucleotide variants in neurexin/neuroligin revealed in clinical genomic sequencing.
Xue K et al.
Journal of Biomolecular Structure & Dynamics, 2022
A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder.
Purushotham SS et al.
Experimental Brain Research, 2022
Imaging neural circuit pathology of autism spectrum disorders: autism-associated genes, animal models and the application of in vivo two-photon imaging.
Terashima H et al.
Microscopy (oxford, England), 2022
GABAergic System Dysfunction in Autism Spectrum Disorders.
Zhao H et al.
Frontiers in Cell and Developmental Biology, 2021
Autism-associated variants of neuroligin 4X impair synaptogenic activity by various molecular mechanisms.
Yumoto T et al.
Molecular Autism, 2020
GABAergic deficits and schizophrenia-like behaviors in a mouse model carrying patient-derived neuroligin-2 R215H mutation.
Jiang DY et al.
Molecular Brain, 2018
Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity.
Parente DJ et al.
American Journal of Medical Genetics. Part A, 2017
Neuroligin 2 R215H Mutant Mice Manifest Anxiety, Increased Prepulse Inhibition, and Impaired Spatial Learning and Memory.
Chen CH et al.
Frontiers in Psychiatry, 2017
Identification and functional characterization of rare mutations of the neuroligin-2 gene (NLGN2) associated with schizophrenia.
Sun C et al.
Human Molecular Genetics, 2011
Select a paper to view details